Cigna Group exited several major Russell benchmarks. The removal includes the Russell 1000 and 3000 Growth and Defensive indices. This move forces rebalancing among investors and quantitative funds tracking these benchmarks.
Brian Evanko will succeed David Cordani as CEO on July 1, 2026. The index exit increases market focus on Evanko’s future strategy for the Evernorth health services unit.
Management must also navigate rising regulatory scrutiny regarding pharmacy benefit manager (PBM) practices. Cigna’s investment case now relies on its ability to drive earnings growth through Evernorth.